报告题目：Transdermal Sensing: Beyond Glucose
报告人：Tony Cass 教授
报告时间：2024年1月13日（星期六）15:00
报告地点：科技创新大楼C501会议室
报告摘要
Over the past forty years advances in sensor and associated technologies have lead to widely available and generally well accepted continuous glucose monitors (CGM's) that are advancing the management of diabetes. The current generation of CGM's are also being adopted by otherwise healthy individuals to gain greater insight into their personalised responses to changes in diet and lifestyle more generally. This take-up of what were originally purely medical devices follows similar transitions to consumer products such as watches that measure SpO2, heart rate or ECG.
Both the clinical and consumer advances in CGM therefore pose the questions of what other molecular biomarkers could be measured through the transdermal route and what technological developments are necessary to achieve this.
In this presentation I will describe one particular approach in detail, that of using microneedles, and highlight both the progress so far as well as the challenges remaining.
个人简介
Undergraduate degree from University of York
PhD from University of Oxford
Professor of Chemical Biology, Department of Chemistry and Institute of Biomedical Engineering at Imperial College London
Fellow of both the Royal Society of Chemistry and Society of Biology
Director of Agilent Research Center
Royal Society's Mullard Medal
Chemical Landmark Award
Member of several Research Council Committees and TSB panels in the UK
Member of the Scientific Advisory Boards of PlastiCell Ltd and SabiliTech Ltd
Visiting Professor of the Chinese Academy of Sciences and Visting Professor at Universiti Teknologi Malaysia and the University of Rome, La Sapienza
Winner of the “Qiming Plan” of the Organization Department of the CPC Central Committee in 2023
Research interests are in the field of analytical biotechnology, including the use of molecular engineering and design for the production of new reagents for both biosensors and bioassays, and the microfabrication of device structures;
Pioneered the use of synthetic electron transport media in enzyme biosensors, and the work in this field led to the development of the first electronic blood glucose measurement system, which was industrialized by MediSense Company Limited (now Abbott Diagnostics);
Published over 150 papers and edited 3 books and is on the editorial boards of Nanobioscience and IET Proceedings Nanobiotechnology.
当前位置：
